Drawing for MYIPS

USPTO serial 79296099

MYIPS

Reviewed by CopyMark Law Group

Reg. 6564685Status 700Renewal
Filing date
Status date
Registration date
Nov 23, 2021
Examiner
WINTER, MELISSA S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MYIPS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research and scientific purposes; stem cells, other than for medical or veterinary purposes; industrial chemicals; chemical test paper, other than for medical purposes; cell culture reagents for laboratory use; cell culture media for scientific or research purposes; biological preparation for use in cell cultures other than for medical or veterinary useACTIVE
005Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paper being reagent paper for medical purposes; living cells for medical use; cells for medical use; tissues for medical use, namely, biological tissue cultures for medical purposesACTIVE
039Storage of frozen living cells; storage of biological tissues, cells and stem cells; warehousing services for deposited articlesACTIVE
042Scientific research on stem cells; cell culture services for scientific and research purposes, for others; cytogenetic examination for research purposes; scientific testing, examination for medical research purposes, research and development in the field of cytology; scientific testing, examination for medical research purposes, research and development in the field of regenerative medicine; testing, examination, research and development of pharmaceuticals; conducting clinical studies for others; medical laboratory services; providing quality assurance in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on medical research and testing for medical research purposes related to stem cells; providing information related to research and development of pharmaceutical preparations; scientific testing, examination for medical research purposes and research of medical therapy methods and technologies; testing, examination and research of cosmetics and foods; design and development of computer hardware and computer software for use in the field of medical science; design and development of machines, apparatus, instruments and systems in the field of medical science; design, development and maintenance of computer programs; testing the functionality of and performing research on machines, apparatus, and instruments in the field of medical science; rental of laboratory apparatus and instrumentsACTIVE
044Stem cell therapy services; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissues, blood and cells; medical treatment and diagnosis services in the nature of regenerative therapy by using a cell culture ; cell culture bank services for medical transplantation ; medical care; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis in the nature of regenerative therapy by regenerative medicine; medical cell therapy and diagnosis services in the nature of regenerative cell therapy; medical treatment and consulting services in the nature of regenerative cell therapy by cell preparations; preservation of human blood for stem cells; providing medical information and medical record analysis for use in medical treatment ; clinical medical examination services; providing health care services; preparation and dispensing of medications; physical examination services; dentistry services; providing health information; dietary and nutritional guidance; rental of medical apparatus and instrumentsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 6, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 12, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
May 11, 2022FIMPFINAL DISPOSITION PROCESSED
Feb 23, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 7, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 5, 2021GPNXNOTIFICATION PROCESSED BY IB
Aug 18, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 18, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 18, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 2, 2021ALIEASSIGNED TO LIE
Aug 2, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 2, 2021XAECEXAMINER'S AMENDMENT ENTERED
Aug 2, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 2, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Aug 2, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2021RFNTREFUSAL PROCESSED BY IB
Feb 7, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 7, 2021RFRRREFUSAL PROCESSED BY MPU
Jan 29, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 28, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2021DOCKASSIGNED TO EXAMINER
Oct 23, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Oct 19, 2020DOCKASSIGNED TO EXAMINER
Oct 19, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance